Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in CSPN with Metabolic Syndrome
NCT02878798Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Feb 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in cryptogenic sensory peripheral neuropathy (CSPN), sponsored by Virginia Commonwealth University. Started Feb 2018; status: completed.
02
Drugs
topiramate
03
Conditions
cryptogenic sensory peripheral neuropathy (CSPN)
Beyond the preview
Go deeper on NCT02878798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878798.